Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial
Alexia Verroken(Cliniques Universitaires Saint-Luc), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Ahalieyah Anantharajah(Cliniques Universitaires Saint-Luc), Julien Favresse(University of Namur), Hector Rodriguez‐Villalobos(Cliniques Universitaires Saint-Luc), Xavier Wittebole(Cliniques Universitaires Saint-Luc)
Cited by 11
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890